Shandong Sinoglory Health Food Co., Ltd (SHA:603182)
China · Delayed Price · Currency is CNY 12.03
-0.08 (-0.66%)
At close: Aug 4, 2026
SHA:603182 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,993 | 2,603 | 1,894 | 2,430 | 2,947 | - | |
Market Cap Growth | -15.37% | 37.45% | -22.07% | -17.53% | - | - |
Enterprise Value | 1,851 | 2,484 | 1,658 | 2,026 | 2,474 | - |
Last Close Price | 12.11 | 15.56 | 10.99 | 13.60 | 16.18 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.85 | 27.49 | 17.35 | 22.07 | 25.77 | - |
PS Ratio | 1.37 | 1.88 | 1.27 | 1.43 | 1.83 | - |
PB Ratio | 1.76 | 2.36 | 1.76 | 2.36 | 3.05 | - |
P/TBV Ratio | 1.93 | 2.59 | 1.95 | 2.63 | 3.38 | - |
P/FCF Ratio | 48.07 | 105.74 | - | - | 46.13 | - |
P/OCF Ratio | 22.43 | 32.80 | 6.04 | 65.09 | 27.00 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.27 | 1.79 | 1.11 | 1.20 | 1.53 | - |
EV/EBITDA Ratio | 9.40 | 12.92 | 10.15 | 11.54 | 13.88 | - |
EV/EBIT Ratio | 15.79 | 20.39 | 12.73 | 14.35 | 17.10 | - |
EV/FCF Ratio | 44.65 | 100.89 | - | - | 38.73 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.03 | - | 0.20 |
Debt / EBITDA Ratio | 0.05 | 0.05 | 0.15 | 0.20 | - | 0.72 |
Debt / FCF Ratio | 0.25 | 0.38 | - | - | - | 9.76 |
Net Debt / Equity Ratio | -0.12 | -0.08 | -0.11 | -0.26 | -0.45 | -0.09 |
Net Debt / EBITDA Ratio | -0.72 | -0.44 | -0.75 | -1.54 | -2.45 | -0.31 |
Net Debt / FCF Ratio | -3.42 | -3.43 | 1.43 | 2.31 | -6.84 | -4.17 |
Asset Turnover | 1.02 | 0.99 | 1.10 | 1.37 | 1.62 | 1.72 |
Inventory Turnover | 5.80 | 5.11 | 5.99 | 7.28 | 7.74 | 8.30 |
Quick Ratio | 1.57 | 1.11 | 0.84 | 2.80 | 3.79 | 0.85 |
Current Ratio | 3.27 | 2.78 | 1.86 | 4.14 | 5.25 | 1.79 |
Return on Equity (ROE) | 7.69% | 8.69% | 10.37% | 11.04% | 15.96% | 18.47% |
Return on Assets (ROA) | 5.13% | 5.43% | 5.99% | 7.15% | 9.09% | 8.92% |
Return on Invested Capital (ROIC) | 8.92% | 9.33% | 11.64% | 16.29% | 23.34% | 20.05% |
Return on Capital Employed (ROCE) | 9.70% | 10.40% | 11.40% | 12.80% | 14.00% | 18.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.33% | 3.64% | 5.76% | 4.53% | 3.88% | - |
FCF Yield | 2.08% | 0.95% | -4.53% | -4.83% | 2.17% | - |
Dividend Yield | 4.26% | 3.21% | 0.91% | 2.94% | 1.85% | - |
Payout Ratio | 76.35% | 69.74% | 60.89% | 46.24% | - | 4.96% |
Buyback Yield / Dilution | 1.21% | 1.26% | -0.59% | -23.59% | -7.54% | -0.21% |
Total Shareholder Return | 5.46% | 4.47% | 0.32% | -20.65% | -5.69% | -0.21% |